Product Code: 978-1-68038-840-4
Therapeutic Bed Market Growth & Trends
The global therapeutic bed market size is expected to reach USD 6.5 billion by 2030, registering a CAGR of 5.09% from 2023 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of chronic disorders, such as cancer, heart disorders, neurological disorders, kidney disorders, and others, and the growing geriatric population are the key driving factors for the market. According to the WHO, in 2020, the chronic illness prevalence increased by 57%, which is anticipated to spur market growth in the near future. The COVID-19 outbreak in 2020 increased the demand for therapeutic beds significantly.
The pandemic has boosted the demand for emergency supplies, medicines, and medical equipment, such as ventilators, and hospital beds, as a result of increased hospital admissions. In addition, firms are also adopting several strategies, such as collaborations and new product launches, to help healthcare workers. For instance, in August 2020, Project C.U.R.E. received 22,500 Emergency Relief Bed (ERB) sets from Stryker. A mattress, IV pole, and bed frame were included in the ERB kits. As a result, the market is likely to grow substantially in the near future.
Furthermore, pressure injuries are a common and significant economic challenge for healthcare systems globally, costing the U.S. healthcare system more than USD 23.50 billion each year. Various manufacturers began offering solutions, such as special beds, therapeutic mattresses, and repositioning solutions, to reduce the burden of pressure injuries. Moreover, after the onset of the COVID-19 pandemic, there has been extensive demand for pressure relief beds & mattresses in hospitals and rehabilitation centers. These factors are expected to boost the market growth over the forecast period.
Therapeutic Bed Market Report Highlights
- The clinical beds product segment held the largest share of around 48.75% in 2022.
- High ICU admission rates owing to a rise in the number of accidents, growth in the geriatric population, and outbreaks of life-threatening infectious diseases are driving the segment.
- The acute care beds application segment held the largest share of around 43.0% in 2022.
- This growth was attributed to multifunctional applications, such as managing labor (maternity), providing treatment to the injury, reducing the severity of mental illness, and protecting against exacerbation or complications.
- The market in Europe held a substantial revenue share of 35.7% in 2022 owing to a rise in the number of surgical procedures, high geriatric population, and favorable reimbursement policies in the region.
Table of Contents
Chapter 1 Methodology and Scope
- 1.1 Market Segmentation & Scope
- 1.1.1 Product
- 1.1.2 Application
- 1.1.3 End-use
- 1.1.4 Regional Scope
- 1.1.5 Estimates And Forecast Timeline
- 1.2 Research Methodology
- 1.3 Information Procurement
- 1.3.1 Purchased Database
- 1.3.2 Gvr's Internal Database
- 1.3.3 Secondary Sources
- 1.3.4 Primary Research
- 1.3.5 Details Of Primary Research
- 1.4 Information or Data Analysis
- 1.4.1 Data Analysis Models
- 1.5 Market Formulation & Validation
- 1.6 Model Details
- 1.6.1 Commodity Flow Analysis (Model 1)
- 1.6.2 Volume Price Analysis (Model 2)
- 1.7 List of Secondary Sources
- 1.8 List of Primary Sources
- 1.9 List of Abbreviations
- 1.10 Objectives
Chapter 2 Executive Summary
- 2.1 Market Outlook
- 2.2 Segment Outlook
- 2.3 Competitive Scenario
Chapter 3 Therapeutic Beds Market: Variables, Trends, & Scope
- 3.1 Market Segmentation and Scope
- 3.2 Market Driver Analysis
- 3.2.1 Increasing prevalence of chronic diseases requiring long-term care
- 3.2.2 Growing demand for home healthcare
- 3.2.3 Improvements in public and private hospital infrastructure
- 3.2.4 Growing geriatric population
- 3.3 Market Restraint Analysis
- 3.3.1 High cost of therapeutic beds
- 3.3.2 Limited availability of technology and funds preventing indigenous manufacturing in emerging economies
- 3.4 Market Opportunities Analysis
- 3.4.1 Technological advancements by manufacturers
- 3.4.2 Increasing launch of delivery beds IS expected to drive growth of the global therapeutic bed market
- 3.5 Penetration & Growth Prospect Mapping
- 3.6 Porter's Five Forces Analysis
- 3.7 PESTEL Analysis
- 3.8 Impact of COVID-18 & Post-COVID Recovery Analysis
Chapter 4 Therapeutic Beds Market: Product Segment Analysis, 2018 - 2030 (USD Million)
- 4.1 Definition and Scope
- 4.2 Product Market Share Analysis, 2022 & 2030
- 4.3 Segment Dashboard
- 4.4 Global Therapeutic Beds Market, by Product, 2018 - 2030
- 4.5 Market Size & Forecasts and Trend Analyses, 2018 - 2030
- 4.5.1 Clinical Beds
- 4.5.1.1 Clinical beds market, 2018 - 2030 (USD Million)
- 4.5.1.2 Regular beds market, 2018 - 2030 (USD Million)
- 4.5.1.3 ICU beds market, 2018 - 2030 (USD Million)
- 4.5.1.4 Pediatric beds market, 2018 - 2030 (USD Million)
- 4.5.1.5 Birthing beds market, 2018 - 2030 (USD Million)
- 4.5.1.6 Bariatric beds market, 2018 - 2030 (USD Million)
- 4.5.1.7 Low air loss beds beds market, 2018 - 2030 (USD Million)
- 4.5.1.8 Others market, 2018 - 2030 (USD Million)
- 4.5.2 Household Beds
- 4.5.2.1 Household Beds Market, 2018 - 2030 (Usd Million)
- 4.5.3 Accessories
- 4.5.3.1 Accessories market, 2018 - 2030 (USD Million)
Chapter 5 Therapeutic Beds Market: Application Segment Analysis, 2018 - 2030 (USD Million)
- 5.1 Definition and Scope
- 5.2 Application Market Share Analysis, 2022 & 2030
- 5.3 Segment Dashboard
- 5.4 Global Therapeutic Beds Market, by Application, 2018 - 2030
- 5.5 Market Size & Forecasts and Trend Analyses, 2018 - 2030
- 5.5.1 Acute Care Beds
- 5.5.1.1 Acute Care Beds Market, 2018 - 2030 (Usd Million)
- 5.5.2 Critical Care Beds
- 5.5.2.1 Critical Care Beds Market, 2018 - 2030 (Usd Million)
- 5.5.3 Long-Term Beds
- 5.5.3.1 Long-term beds market, 2018 - 2030 (USD Million)
Chapter 6 Therapeutic Beds Market: End-use Segment Analysis, 2018 - 2030 (USD Million)
- 6.1 Definition and Scope
- 6.2 End-use Market Share Analysis, 2022 & 2030
- 6.3 Segment Dashboard
- 6.4 Global Therapeutic Beds Market, by End-use, 2018 - 2030
- 6.5 Market Size & Forecasts and Trend Analyses, 2018 - 2030
- 6.5.1 Hospitals & Clinics
- 6.5.1.1 Hospital & Clinics Market, 2018 - 2030 (Usd Million)
- 6.5.2 Reproductive Care Centers
- 6.5.2.1 Reproductive Care Centers Market, 2018 - 2030 (Usd Million)
- 6.5.3 Others
- 6.5.3.1 Others market, 2018 - 2030 (USD Million)
Chapter 7 Therapeutic Beds Market: Regional Market Analysis, By Product, By Application, By End-Use, 2018 - 2030 (USD Million)
- 7.1 Therapeutic Beds: Market Share Analysis, 2022
- 7.2 North America
- 7.2.1 North America therapeutic beds market, 2017 - 2030 (USD Million)
- 7.2.2 U.S.
- 7.2.2.1 Key Country Dynamics
- 7.2.2.2 Regulatory Framework & Reimbursement Scenario
- 7.2.2.3 Competitive Scenario
- 7.2.2.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)
- 7.2.3 Canada
- 7.2.3.1 Key Country Dynamics
- 7.2.3.2 Regulatory Framework & Reimbursement Scenario
- 7.2.3.3 Competitive Scenario
- 7.2.3.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)
- 7.3 Europe
- 7.3.1 Europe therapeutic beds market, 2017 - 2030 (USD Million)
- 7.3.2 UK
- 7.2.3.1 Key Country Dynamics
- 7.2.3.2 Regulatory Framework & Reimbursement Scenario
- 7.2.3.3 Competitive Scenario
- 7.2.3.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)
- 7.3.3 Germany
- 7.3.3.1 Key Country Dynamics
- 7.3.3.2 Regulatory Framework & Reimbursement Scenario
- 7.3.3.3 Competitive Scenario
- 7.3.3.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)
- 7.3.4 France
- 7.3.4.1 Key Country Dynamics
- 7.3.4.2 Regulatory Framework & Reimbursement Scenario
- 7.3.4.3 Competitive Scenario
- 7.3.4.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)
- 7.3.5 Italy
- 7.3.5.1 Key Country Dynamics
- 7.3.5.2 Regulatory Framework & Reimbursement Scenario
- 7.3.5.3 Competitive Scenario
- 7.3.5.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)
- 7.3.6 Spain
- 7.3.6.1 Key Country Dynamics
- 7.3.6.2 Regulatory Framework & Reimbursement Scenario
- 7.3.6.3 Competitive Scenario
- 7.3.6.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)
- 7.3.7 Denmark
- 7.3.7.1 Key Country Dynamics
- 7.3.7.2 Regulatory Framework & Reimbursement Scenario
- 7.3.7.3 Competitive Scenario
- 7.3.7.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.3.8 Sweden
- 7.3.8.1 Key Country Dynamics
- 7.3.8.2 Regulatory Framework & Reimbursement Scenario
- 7.3.8.3 Competitive Scenario
- 7.3.8.4 Market Estimates & Forecasts, 2018 - 2030 (USD Million)
- 7.3.9 Norway
- 7.3.9.1 Key Country Dynamics
- 7.3.9.2 Regulatory Framework & Reimbursement Scenario
- 7.3.9.3 Competitive Scenario
- 7.3.9.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)
- 7.4 Asia Pacific
- 7.4.1 Asia Pacific therapeutic beds market, 2017 - 2030 (USD Million)
- 7.4.2 Japan
- 7.4.2.1 Key Country Dynamics
- 7.4.2.2 Regulatory Framework & Reimbursement Scenario
- 7.4.2.3 Competitive Scenario
- 7.4.2.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)
- 7.4.3 China
- 7.4.3.1 Key Country Dynamics
- 7.4.3.2 Regulatory Framework & Reimbursement Scenario
- 7.4.3.3 Competitive Scenario
- 7.4.3.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)
- 7.4.4 India
- 7.4.4.1 Key Country Dynamics
- 7.4.4.2 Regulatory Framework & Reimbursement Scenario
- 7.4.4.3 Competitive Scenario
- 7.4.4.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)
- 7.4.5 Australia
- 7.4.5.1 Key Country Dynamics
- 7.4.5.2 Regulatory Framework & Reimbursement Scenario
- 7.4.5.3 Competitive Scenario
- 7.4.5.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)
- 7.4.6 South Korea
- 7.4.6.1 Key Country Dynamics
- 7.4.6.2 Regulatory Framework & Reimbursement Scenario
- 7.4.6.3 Competitive Scenario
- 7.4.6.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)
- 7.4.7 Thailand
- 7.4.7.1 Key Country Dynamics
- 7.4.7.2 Regulatory Framework & Reimbursement Scenario
- 7.4.7.3 Competitive Scenario
- 7.4.7.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)
- 7.5 Latin America
- 7.5.1 Latin America therapeutic beds market, 2017 - 2030 (USD Million)
- 7.5.2 Brazil
- 7.5.2.1 Key Country Dynamics
- 7.5.2.2 Regulatory Framework & Reimbursement Scenario
- 7.5.2.3 Competitive Scenario
- 7.5.2.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)
- 7.5.3 Mexico
- 7.5.3.1 Key Country Dynamics
- 7.5.3.2 Regulatory Framework & Reimbursement Scenario
- 7.5.3.3 Competitive Scenario
- 7.5.3.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)
- 7.5.4 Argentina
- 7.5.4.1 Key Country Dynamics
- 7.5.4.2 Regulatory Framework & Reimbursement Scenario
- 7.5.4.3 Competitive Scenario
- 7.5.4.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)
- 7.6 MEA
- 7.6.1 MEA therapeutic beds market, 2017 - 2030 (USD Million)
- 7.6.2 South Africa
- 7.6.2.1 Key Country Dynamics
- 7.6.2.2 Regulatory Framework & Reimbursement Scenario
- 7.6.2.3 Competitive Scenario
- 7.6.2.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)
- 7.6.3 Saudi Arabia
- 7.6.3.1 Key Country Dynamics
- 7.6.3.2 Regulatory Framework & Reimbursement Scenario
- 7.6.3.3 Competitive Scenario
- 7.6.3.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)
- 7.6.4 UAE
- 7.6.4.1 Key Country Dynamics
- 7.6.4.2 Regulatory Framework & Reimbursement Scenario
- 7.6.4.3 Competitive Scenario
- 7.6.4.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)
- 7.6.5 Kuwait
- 7.6.5.1 Key Country Dynamics
- 7.6.5.2 Regulatory Framework & Reimbursement Scenario
- 7.6.5.3 Competitive Scenario
- 7.6.5.4 Market Estimates & Forecasts, 2017 - 2030 (USD Million)
Chapter 8 Company Profiles
- 8.1 Company Profiles
- 8.1.1 HILL-ROM SERVICES, INC. (BAXTER)
- 8.1.1.1 Company overview
- 8.1.1.2 Financial performance
- 8.1.1.3 Product benchmarking
- 8.1.2 ARJOHUNTLEIGH (ARJO)
- 8.1.2.1 Company overview
- 8.1.2.2 Financial performance
- 8.1.2.3 Product benchmarking
- 8.1.3 Invacare Corporation
- 8.1.3.1 Company overview
- 8.1.3.2 Financial performance
- 8.1.3.3 Product benchmarking
- 8.1.4 STRYKER
- 8.1.4.1 Company overview
- 8.1.4.2 Product benchmarking
- 8.1.5 MEDLINE INDUSTRIES, INC.
- 8.1.5.1 Company overview
- 8.1.5.2 Financial performance
- 8.1.5.3 Product benchmarking
- 8.1.6 GF HEALTH PRODUCTS, INC.
- 8.1.6.1 Company overview
- 8.1.6.2 Product benchmarking
- 8.1.7 HARD MANUFACTURING COMPANY INC
- 8.1.7.1 Company overview
- 8.1.7.2 Product benchmarking
- 8.1.8 BAKARE BEDS LTD
- 8.1.8.1 Company overview
- 8.1.8.2 Product benchmarking
- 8.1.9 AMICO CORPORATION
- 8.1.9.1 Company overview
- 8.1.9.2 Product benchmarking
- 8.1.10 MEDICAL DEPOT.INC. (DRIVE DEVILBISS HEALTHCARE)
- 8.1.10.1 Company overview
- 8.1.10.2 Product benchmarking
- 8.1.11 GENDRON, INC.
- 8.1.11.1 Company overview
- 8.1.11.2 Product benchmarking